Please use this identifier to cite or link to this item:
DC FieldValue
dc.titleCell-delivery therapeutics for liver regeneration
dc.contributor.authorZhang, W.
dc.contributor.authorChang, S.
dc.contributor.authorJia, R.
dc.contributor.authorShen, S.
dc.contributor.authorYu, H.
dc.contributor.authorTucker-Kellogg, L.
dc.contributor.authorVenkatraman, L.
dc.contributor.authorLu, Y.
dc.contributor.authorWhite, J.K.
dc.contributor.authorBhowmick, S.S.
dc.contributor.authorDewey, C.F.
dc.contributor.authorNarmada, B.C.
dc.contributor.authorTan, N.
dc.identifier.citationZhang, W., Chang, S., Jia, R., Shen, S., Yu, H., Tucker-Kellogg, L., Venkatraman, L., Lu, Y., White, J.K., Bhowmick, S.S., Dewey, C.F., Narmada, B.C., Tan, N. (2010). Cell-delivery therapeutics for liver regeneration. Advanced Drug Delivery Reviews 62 (7-8) : 814-826. ScholarBank@NUS Repository.
dc.description.abstractFor acute, chronic, or hereditary diseases of the liver, cell transplantation therapies can stimulate liver regeneration or serve as a bridge until liver transplantation can be performed. Recently, fetal hepatocytes, stem cells, liver progenitor cells, or other primitive and proliferative cell types have been employed for cell transplantation therapies, in an effort to improve the survival, proliferation, and engraftment of the transplanted cells. Reviewing earlier studies, which achieved success by transplanting mature hepatocytes, we propose that there is a switch-like regulation of liver regeneration that changes state according to a stimulus threshold of extracellular influences such as cytokines, matrices and neighboring cells. Important determinants of a successful clinical outcome include sufficient quantities and functional levels of the transplanted cells (even for short periods to alter the environment), rather than just engraftment levels or survival durations of the exogenously transplanted cells. The relative importance of these determining factors will impact future choices of cell sources, delivery vehicles, and sites of cell transplantation to stimulate liver regeneration for patients with severe liver diseases. © 2010 Elsevier B.V.
dc.subjectCell transplantation
dc.subjectDelivery vehicles
dc.subjectLiver regeneration
dc.subjectStem cells
dc.subjectSystems Biology
dc.subjectXenogenic cells
dc.contributor.departmentCOMPUTER SCIENCE
dc.contributor.departmentSINGAPORE-MIT ALLIANCE
dc.description.sourcetitleAdvanced Drug Delivery Reviews
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.